Clinical trial Recruiting at 13 sites Interventional Ages 3 to 18

Exercise program during cancer treatment for children and teens

Official title: Evaluation of an Exercise Intervention During Intensive Medical Treatment in Pediatric Oncology (Evaluation BEwegungs- Und sPorttherapeutischer Interventionen Unter Medizinischer Therapie in Der Pädiatrischen Onkologie)

Run by Universität Duisburg-Essen · NCT07647471 · Data updated 2026-11-12

A structured, 6-month exercise program is being tested to see if it improves physical and mental health for children and adolescents undergoing cancer treatment.

Quick facts

Study typeInterventional
Ages3 Years to 18 Years
SexAll
Enrollment346 (estimated)
SponsorUniversität Duisburg-Essen
Academic / other
Locations13 sites (Berlin and 12 other locations)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT07647471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 3 to 18 years with a curative-intent cancer diagnosis, within 6 weeks of diagnosis, treated in German statutory health settings, and able to participate in a German/English-supported program.

Probably not a fit

Patients who cannot participate due to medical limitations, non-oncologic treatment plans, or lack of German statutory insurance may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BEPPO study is a Germany-wide randomized trial enrolling 346 pediatric patients aged 3 to 18 who are starting curative cancer therapy. Participants are assigned to either a supervised, partly-standardized exercise program (3-5 sessions per week across hospital, outpatient, and home settings with telemedicine support) or standard care. The trial aims to determine whether regular physical activity during treatment can boost knee extensor strength, fatigue levels, quality of life, and overall well-being, while considering health economic implications and implementation in routine care. The intervention is designed to be continuum-based to provide ongoing support throughout medical treatment. Recruitment spans 13 pediatric oncology centers in Germany, with multiple collaborating institutions involved in leadership, research, and site-wide execution.

Why it matters

Potential benefit: If successful, the program could become a standard part of pediatric oncology care, improving physical strength and quality of life during treatment.

How similar studies have gone: Previous studies in pediatric oncology have suggested exercise can support recovery and well-being, but this broad, nationwide approach with telemedicine support is relatively novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≥3 and ≤18 years
* Oncological diagnosis with curative treatment intent
* ≤6 weeks since cancer diagnosis (diagnosis can be initial, secondary or relapse diagnosis)
* Information and consent procedures feasible in German, English or with using local site resources (e.g., interpreters or multilingual staff)
* Communication with the patient is possible in German, English or with using local site resources (e.g., interpreters or multilingual staff) during the assessments and intervention
* Patients insured by German statutory health insurers

Exclusion Criteria:

* Patients aged \<3 and \>18 years
* No active medical oncological treatment (e.g., watch-and-wait strategy, surgery without ongoing oncological acute treatment at a pediatric oncology center)
* Medical limitations that do not allow implementation of the study protocol
* Life expectancy \< 6 months
* Patients not insured by German statutory health insurers (e.g., Privatly insured patients, self-paying patients)

Where it's running

  • Charité-Universitätsmedizin Berlin, Department of Pediatric Oncology/Hematology
    Berlin, Germany
    Recruiting
  • University of Bonn Medical Center, Department of Pediatric Hematology/Oncology,
    Bonn, Germany
    Recruiting
  • Children's Hospital Amsterdamer Straße, ; Clinic for Children and Youth Medicine; Department for pediatric hematology/oncology
    Cologne, Germany
    Recruiting
  • University Hospital Cologne, Department of Pediatric Oncology and Hematology, Children's Hospital
    Cologne, Germany
    Recruiting
  • University Hospital Essen, Department of Pediatric Hematology/Oncology, Center for Child and Adolescent Medicine, Clinic for Pediatrics III
    Essen, Germany
    Recruiting
  • Universitätsmedizin Frankfurt, Department of Pediatrics, Pediatric Oncology and Haematology
    Frankfurt, Germany
    Recruiting
Show 7 more locations
  • Universitätsklinikum Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hubertus Wald Tumor Center, University Cancer Center Hamburg
    Hamburg, Germany
    Recruiting
  • Universitätsklinikum Jena, Klinik für Kinder- und Jugendmedizin
    Jena, Germany
    Recruiting
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Department of Pediatric Hematology/Oncology
    Mainz, Germany
    Recruiting
  • Pädiatrische Hämatologie und Onkologie, Zelltherapie Zentrum für Kinder- und Jugendmedizin Eine Kooperation der München Klinik und des TUM Klinikums
    München, Germany
    Recruiting
  • DIAKONEO Klinik Hallerwiese-Cnopfsche Kinderklinik Nürnberg, Department of Pediatric Hematology and Oncology
    Nuremberg, Germany
    Recruiting
  • Klinikum der Landeshauptstadt Stuttgart, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie
    Stuttgart, Germany
    Recruiting
  • University Medical Center Ulm, Department of Pediatrics and Adolescent Medicine
    Ulm, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.